Wei-Jern Tsai

Dr. Wei-Jern Tsai


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2005 in Journal of Biomedical Science
Verified
Journal Article
Closed access
PDF file
YKYuh-Chi Kuo
Yuh-Chi Kuo
YLYun-Lian Lin
Yun-Lian Lin
CLChih-Peng Liu
Chih-Peng Liu
WTWei-Jern Tsai
Wei-Jern Tsai

25 March 2011 in Chinese Medicine
Verified
Journal Article
Open access
PDF file
WTWei-Jern Tsai
Wei-Jern Tsai
CCChu-Ting Chang
Chu-Ting Chang
GWGuei-Jane Wang
Guei-Jane Wang
TLTzong-Huei Lee
Tzong-Huei Lee
SCShwu-Fen Chang
Shwu-Fen Chang
YKYuh-Chi Kuo
Yuh-Chi Kuo
Background: Arctium lappa (Niubang), a Chinese herbal medicine, is used to treat tissue inflammation. This study investigates the effects of arctigenin (AC), isolated from A. lappa, on anti-CD3/CD28 Ab-stimulated cell proliferation and cytokine gene expression in primary human T lymphocytes. Methods: Cell proliferation was determined with enzyme immunoassays and the tritiated thymidine uptake method. Cytokine production and gene expression were analyzed with reverse transcription-polymerase chain reaction. Results: AC inhibited primary human T lymphocytes proliferation activated by anti-CD3/CD28 Ab. Cell viability test indicated that the inhibitory effects of AC on primary human T lymphocyte proliferation were not due to direct cytotoxicity. AC suppressed interleukin-2 (IL-2) and interferon-γ (IFN-γ) production in a concentration-dependent manner. Furthermore, AC decreased the IL-2 and IFN-γ gene expression in primary human T lymphocytes induced by anti-CD3/CD28 Ab. Reporter gene analyses revealed that AC decreased NF-AT-mediated reporter gene expression. Conclusion: AC inhibited T lymphocyte proliferation and decreased the gene expression of IL-2, IFN-γ and NF-AT.